Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Revenue | $223K | $254K | $608K | $1.01M |
| Revenue growth | — | 13.6% | 139.6% | 65.5% |
| Gross profit | -$209K | -$221K | $223K | $224K |
| Gross margin | -93.7% | -87.1% | 36.7% | 22.3% |
| Operating income | -$1.75M | -$5.15M | -$9.72M | -$7.76M |
| Operating margin | -784.2% | -2032.8% | -1599.0% | -771.6% |
| Net income | -$6.18M | -$3.77M | -$7.95M | -$7.37M |
| Net margin | -2769.5% | -1485.1% | -1308.0% | -732.5% |
| EPS (diluted) | -$2.61 | -$59.18 | -$74.17 | -$11.73 |
| Fiscal year | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Operating cash flow | -$1.01M | -$4.54M | -$5.65M | -$6.85M |
| Capital expenditures | — | $57.6K | $104K | $140K |
| Free cash flow | — | -$4.60M | -$5.75M | -$6.99M |
| Fiscal year | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| Cash & equivalents | $265K | $2.14M | $1.66M | $1.51M |
| Total assets | $1.30M | $7.78M | $5.76M | $5.37M |
| Total liabilities | $25.4M | $2.99M | $1.80M | $1.99M |
| Long-term debt | — | $150K | $147K | $144K |
| Shareholders' equity | -$23.6M | $4.87M | $4.04M | $3.46M |
| Retained earnings | -$28.8M | -$32.6M | -$40.5M | -$47.9M |
| Shares (wtd avg diluted) | 2.37M | 66.3B | 114K | 670K |
Every figure is extracted from 60 DEGREES PHARMACEUTICALS, INC.’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.